Genetic Resistance to GLP-1 Diabetes Drugs

Ten percent of people carry gene variants that make them resistant to popular GLP-1 diabetes drugs like Ozempic—despite having higher levels of the hormone, their blood sugar doesn’t drop as expected. After a decade of global research across humans and mice, scientists pinpointed a gene that disrupts how GLP-1 signals the body, turning up the fuel but not the engine. This breakthrough could revolutionize personalized diabetes care, helping doctors match patients with the right meds faster—without affecting other diabetes treatments. The discovery opens doors to new drug designs that might finally overcome this genetic barrier. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9cb96b1e5d065124